Initial Steps in Ascent to Assent for Pediatric Critical Care Research.
Initial Steps in Ascent to Assent for Pediatric Critical Care Research.
复制标题
获得儿科重症监护研究同意的初步步骤。
DOI:
10.1097/pcc.0000000000003144
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Zimmerman,JerryJ
中科院分区:
文献类型:
--
作者:
Zimmerman,JerryJ
Including children in research is recognized as a moral imperative based on several ethical principles including distributive justice for high-quality healthcare availability to all populations (1), beneficence in providing evidence-based care (the goal of the Best Pharmaceuticals for Children Act [2]), and nonmaleficence in avoiding harmful therapies (therapy creep based on plausibility alone or adult experience but lack of quality data regarding benefit/harm)(3). Equity mandates the inclusion of children in research, and children should be involved in the decision to take part in research as appropriate for their developmental capacity (4). Assent is the notion of providing agreement to participate in research when full consent is not possible (5). Although the concept of assent is readily justifiable, its application in pediatric critical care research remains challenging.Within this context, in this issue of Pediatric Critical Care Medicine, O’Hearn et al (6), on behalf of the Canadian Critical Care Trials Group, report the results of an anonymous cross-sectional survey study involving 14 tertiary care pediatric hospitals in Canada with a goal of clarifying the role of assent in pediatric critical care research. With significant experience in survey research, the investigators describe perspectives of assent provided by 193 respondents including research ethics board chairs, research coordinators, critical care nurses, and researchers (mostly PICU attending physicians) focusing on pediatric critical care. Overall for all scenarios presented, at least 50% of respondents indicated that it was “important/very important” to seek assent from children involved with critical care research. Anyone who has been involved in recruiting critically ill children/families into clinical research studies can ascertain the unique challenges imposed by ongoing shock, tracheal intubation, sedation, chemical paralysis, residual anesthesia, baseline developmental disability, delirium, unresolved pain and anxiety, infection isolation, and parental guilt. Incredulously, 35% of survey respondents reported no barriers to assent at the time of enrollment that are unique to the PICU. Additionally, 18% of respondents indicated it was “always or almost always” possible to obtain assent during the first 24–48 hours of a child’s PICU admission. These read like disheartening responses for a dedicated clinical trials group endeavoring to develop some consensus around the concept of assent.